| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 2 Mar 2026 | 2 Mar 2026 |
| Board Meeting Outcome for Approval Of Allotment Of Shares W.R.T. Rights Issue Of The Company Revised Outcome | ||
| Board Meeting | 12 Feb 2026 | 12 Feb 2026 |
| Outcome of Board Meeting held today i.e. Thursday, 12th February, 2026 | ||
| Board Meeting | 5 Feb 2026 | 2 Feb 2026 |
| Right Issue of Equity Shares The Record Date is Wednesday, 11th February, 2026, for the purpose of ascertaining the eligibility of equity shareholders entitled to receive 19 (Nineteen) Rights Equity Shares for every 41 (Forty-One) fully paid-up Equity Shares held by the eligible equity shareholders of the Company on a rights basis (Record Date). (As Per BSE Announcement Dated on 05.02.2026) | ||
| Board Meeting | 29 Jan 2026 | 26 Jan 2026 |
| Stallion India Fluorochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2026 inter alia to consider and approve Intimation of Board Meeting to consider approve and take on record Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended on 31st December 2025. Outcome of Board Meeting held on 29th January, 2026 for approval of Unaudited Financial Results of the Company for the quarter & Nine Months ended December 31, 2025, along with the Limited Review Report issued by the Statutory Auditors. (As Per BSE Announcement Dated on:29.01.2026) | ||
| Board Meeting | 23 Jan 2026 | 18 Jan 2026 |
| Stallion India Fluorochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2026 inter alia to consider and approve To consider inter alia the proposal of fund raising by way of Equity Shares or any other securities through appropriate mode including rights issue as may be permitted under applicable law. Board considered and approved the 1. Issue of [ ] Equity Shares having a face value of Rs. 10.00/- each for cash at an Issue Price of Rs. [ ] per Equity Share, aggregating upto Rs. 364.00 Crores (Rupees Three Hundred Sixty-Four Crores Only), to the eligible equity shareholders of the Company as on the Record date (to be determined by the Board in due course) on a rights basis (Rights Issue). (As Per BSE Announcement Dated On : 23.01.2026) Stallion India Fluorochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2026 ,inter alia, to consider and approve As per the attachment. (As per BSE Announcement dated on: 21.01.2026) | ||
| Board Meeting | 13 Oct 2025 | 8 Oct 2025 |
| Stallion India Fluorochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/10/2025 inter alia to consider and approve Consider approve & take on record the unaudited Financial Results of the Company for the quarter and half year ended 30th September 2025. Outcome of the Board Meeting for Financial Results of Q2 of FY26. (As per BSE Announcement dated on: 13.10.2025) | ||
| Board Meeting | 8 Aug 2025 | 31 Jul 2025 |
| Quarterly Results Stallion India Fluorochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 ,inter alia, to consider and approve Consider, approve & take on record the unaudited Financial Results of the Company for the quarter ended 30th June, 2025. To consider the proposal for raising of funds, in one or more tranches, by way of issue of equity shares and/or any other instruments or eligible securities representing either equity shares and/or convertible securities linked to equity shares or through any other permissible mode or a combination thereof, including but not limited to public issue(s), debt issue(s), preferential issue(s), private placement(s), qualified institutions placement(s) and/or any combination thereof or any other method as may be permitted under applicable laws, including under the applicable provisions of the Companies Act, 2013 and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, (each as amended), ....as per the file attached herewith. Outcome of the Board Meeting along with the results of Q1 of FY26 (As per BSE Announcement Dated on 08/08/2025) | ||
| Board Meeting | 16 May 2025 | 10 May 2025 |
| Stallion India Fluorochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 inter alia to consider and approve meeting of the Board of Directors of the Company is scheduled on 16/05/2025 inter alia to consider and approve the Annual Financial Results of the Company for the financial year ended on 31st March 2025. Financial Results for the financial year ended on 31st March, 2025. (As Per BSE Announcement Dated on 16.05.2025) | ||
| Board Meeting | 8 Apr 2025 | 8 Apr 2025 |
| Appointment of Mr. Virenderkumar Mehta as Chief Financial Officer of the Company w.e.f. April 8, 2025. Appointment of Mr. Ameetkumar Mehta as Non Executive Independent Director w.e.f. April 8, 2025 | ||
It will also turn out several other blends used in cooling and refrigeration including R-410A, R-404A, R-407C, R-454B, R-515B and R-513A.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
